{"AllianceGenome": "1580", "HGNC": "1580", "MIM": "602755", "_id": "9133", "_version": 1, "accession": {"genomic": ["AC092757.2", "AF545815.1", "AY864066.1", "CH471082.1", "CP068263.2", "HH771252.1", "NC_000015.10", "NC_060939.1"], "protein": ["AAD09309.1", "AAI05087.1", "AAI05113.1", "AAP50918.1", "AAP97207.1", "AAV38265.1", "AAW34361.1", "BAA78387.1", "BAD96331.1", "BAG50905.1", "CAB45739.1", "CAG38558.1", "CAO99274.1", "CBX86331.1", "EAW77563.1", "NP_004692.1", "O95067.1"], "rna": ["AB020981.1", "AF002822.1", "AF087910.1", "AK001404.1", "AK222611.1", "AL080146.1", "AM851054.1", "BC105086.1", "BC105112.1", "BT019458.1", "BU934242.1", "CR533527.1", "NM_004701.4"], "translation": [{"protein": "CAB45739.1", "rna": "AL080146.1"}, {"protein": "AAD09309.1", "rna": "AF002822.1"}, {"protein": "CAO99274.1", "rna": "AM851054.1"}, {"protein": "AAP97207.1", "rna": "AF087910.1"}, {"protein": "AAI05113.1", "rna": "BC105112.1"}, {"protein": "BAA78387.1", "rna": "AB020981.1"}, {"protein": "AAI05087.1", "rna": "BC105086.1"}, {"protein": "AAV38265.1", "rna": "BT019458.1"}, {"protein": "NP_004692.1", "rna": "NM_004701.4"}, {"protein": "BAD96331.1", "rna": "AK222611.1"}, {"protein": "BAG50905.1", "rna": "AK001404.1"}, {"protein": "CAG38558.1", "rna": "CR533527.1"}]}, "alias": "HsT17299", "ensembl": {"gene": "ENSG00000157456", "protein": ["ENSP00000288207", "ENSP00000453685", "ENSP00000480809"], "transcript": ["ENST00000288207", "ENST00000559301", "ENST00000559622", "ENST00000561077", "ENST00000621385"], "translation": [{"protein": "ENSP00000288207", "rna": "ENST00000288207"}, {"protein": "ENSP00000453685", "rna": "ENST00000559622"}, {"protein": "ENSP00000480809", "rna": "ENST00000621385"}], "type_of_gene": "protein_coding"}, "entrezgene": "9133", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 18.8991730627, "exp_mis": 117.481270258, "exp_syn": 48.5043614796, "lof_z": 1.57204627681189, "mis_z": -0.384419491424024, "mu_lof": 1.44209385922e-06, "mu_mis": 1.06093356325e-05, "mu_syn": 4.22487143189e-06, "n_lof": 12.0, "n_mis": 126.0, "n_syn": 65.0, "p_li": 1.58542348538884e-06, "p_null": 0.146187780011735, "p_rec": 0.85381063456478, "syn_z": -1.46834551117334}, "bp": 1197, "cds_end": 59417076, "cds_start": 59397467, "n_exons": 9, "nonpsych": {"exp_lof": 16.9340955241, "exp_mis": 106.160409193, "exp_syn": 43.7296497823, "lof_z": 1.89351350128533, "mis_z": -0.236913507419284, "mu_lof": 1.44209385922e-06, "mu_mis": 1.06093356325e-05, "mu_syn": 4.22487143189e-06, "n_lof": 9.0, "n_mis": 111.0, "n_syn": 62.0, "p_li": 0.000136859145330891, "p_null": 0.0466992533733384, "p_rec": 0.953163887481331, "syn_z": -1.73949171680506}, "nontcga": {"exp_lof": 17.3705251736, "exp_mis": 108.066061716, "exp_syn": 44.6073016994, "lof_z": 1.50782179020218, "mis_z": -0.140609971813979, "mu_lof": 1.44209385922e-06, "mu_mis": 1.06093356325e-05, "mu_syn": 4.22487143189e-06, "n_lof": 11.0, "n_mis": 111.0, "n_syn": 63.0, "p_li": 4.85684742443089e-06, "p_null": 0.144984233671149, "p_rec": 0.855010909481427, "syn_z": -1.74367209718751}, "transcript": "ENST00000288207.2"}, "exons": [{"cdsend": 59124877, "cdsstart": 59105268, "chr": "15", "position": [[59105145, 59105292], [59107321, 59107450], [59107556, 59107670], [59114443, 59114614], [59114717, 59114876], [59116689, 59116926], [59117227, 59117368], [59123516, 59123627], [59124766, 59125045]], "strand": 1, "transcript": "NM_004701", "txend": 59125045, "txstart": 59105145}], "exons_hg19": [{"cdsend": 59417076, "cdsstart": 59397467, "chr": "15", "position": [[59397344, 59397491], [59399520, 59399649], [59399755, 59399869], [59406642, 59406813], [59406916, 59407075], [59408888, 59409125], [59409426, 59409567], [59415715, 59415826], [59416965, 59417244]], "strand": 1, "transcript": "NM_004701", "txend": 59417244, "txstart": 59397344}], "generif": [{"pubmed": 11960377, "text": "Overexpression of B-type cyclins alters chromosomal segregation"}, {"pubmed": 12482752, "text": "p300 binds to multiple NF-Y trimers to regulate cyclin B2 promoter function"}, {"pubmed": 17289878, "text": "cyclin B2 expression in colorectal adenocarcinoma is dependent on NF-Y"}, {"pubmed": 17533373, "text": "severe reduction by separate RNA interference of either cyclin B1 or cyclin B2 protein levels results in little or no alteration of the cell cycle and, more specifically, of mitosis progression"}, {"pubmed": 17549666, "text": "This gene may be used as a very reliable biomarker of lung adenocarcinoma."}, {"pubmed": 18692784, "text": "The CCNA1, CCNB1, CCNB2, PRM1, and PRM2 messenger RNA transcript ratios were significantly decreased in patients with spermatogenic disorders. Transcript ratios in patients with successful sperm retrieval were higher than with failed sperm retrieval."}, {"pubmed": 19664331, "text": "The radiosensitizing effect of paclitaxel on KB cells may be due to the down-regulated expression of PRC1 and cyclin B2."}, {"pubmed": 19738611, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20660152, "text": "Data suggest that cyclin A2 helps initiate mitosis, in part through its effects on cyclin B1, and that cyclins B1 and B2 are particularly critical for the maintenance of the mitotic state."}, {"pubmed": 21161946, "text": "The relative expression level of circulating CCNB2 mRNA in cancer patients was significantly higher than that in normal controls and benign diseases group. Circulating CCNB2 mRNA level significantly correlated with cancer stage and metastasis status."}, {"pubmed": 23282137, "text": "Suggest that cytoplasmic CCNB2 may function as an oncogene and could serve as a potential biomarker of unfavorable prognosis over short-term follow-up in breast cancer."}, {"pubmed": 24324638, "text": "Cyclin B1 and cyclin B2 are interchangeable for ability to promote G2 and M transition in HeLa cells."}, {"pubmed": 24375198, "text": "there was no significance in the 5-year overall survival rates among the patients with squamous cell carcinoma between expressing lower and higher level of cyclin B2 mRNA"}, {"pubmed": 26349989, "text": "overexpression of CCNB2 protein is associated with clinical progression and poor prognosis in non-small cell lung cancer"}, {"pubmed": 26706119, "text": "Data show that the cyclin B2 was overexpressed in bladder cancer tissue."}, {"pubmed": 27183908, "text": "Data show that Islet-1 (ISL1) activated the expression of cyclin B1 (CCNB1), cyclin B2 (CCNB2) and c-myc (c-MYC) genes by binding to the conserved binding sites on their promoters or enhancers."}, {"pubmed": 30816525, "text": "nuclear division cycle 80, cyclin B2 and topoisomerase 2alpha may serve important roles in adrenocortical tumor development."}, {"pubmed": 31101236, "text": "CCNB2 may serve as a prognostic factor and participated in the development and progression and promote cell proliferation and migration through CCNB2/PLK1 pathway in Human Hepatocellular Carcinoma."}, {"pubmed": 31278532, "text": "Cyclin B2 gene is overexpressed in osteosarcoma and associated with poor prognosis outcomes in osteosarcoma patients."}, {"pubmed": 31844417, "text": "MicroRNA-582-3p negatively regulates cell proliferation and cell cycle progression in acute myeloid leukemia by targeting CCNB2."}, {"pubmed": 32202926, "text": "Roles of CCNB2 and NKX3-1 in Nasopharyngeal Carcinoma."}, {"pubmed": 32287321, "text": "CCNB2 was upregulated in cortisol-producing adrenocortical carcinoma with TP53 somatic variant. CCNB2 overexpression was associated with atypical mitotic figures."}, {"pubmed": 32416689, "text": "Potential Prognostic Predictors and Molecular Targets for Skin Melanoma Screened by Weighted Gene Co-expression Network Analysis."}, {"pubmed": 32685486, "text": "CCNB2, TOP2A, and ASPM Reflect the Prognosis of Hepatocellular Carcinoma, as Determined by Weighted Gene Coexpression Network Analysis."}, {"pubmed": 32863381, "text": "CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma."}, {"pubmed": 34193281, "text": "Single-cell chromatin accessibility landscape of human umbilical cord blood in trisomy 18 syndrome."}, {"pubmed": 34354775, "text": "Cyclin B2 (CCNB2) Stimulates the Proliferation of Triple-Negative Breast Cancer (TNBC) Cells In Vitro and In Vivo."}, {"pubmed": 34512164, "text": "CCNB2/SASP/Cathepsin B & PGE2 Axis Induce Cell Senescence Mediated Malignant Transformation."}, {"pubmed": 34908101, "text": "CCNB2 is a novel prognostic factor and a potential therapeutic target in low-grade glioma."}, {"pubmed": 35082401, "text": "CRHBP is degraded via autophagy and exerts anti-hepatocellular carcinoma effects by reducing cyclin B2 expression and dissociating cyclin B2-CDK1 complex."}, {"pubmed": 35384228, "text": "Mad2 promotes Cyclin B2 recruitment to the kinetochore for guiding accurate mitotic checkpoint."}, {"pubmed": 35839486, "text": "Hsa_circ_0000285 knockdown inhibits the progression of hepatocellular carcinoma by sponging miR-582-3p to regulate CCNB2 expression."}, {"pubmed": 38166895, "text": "Cyclin B2 impairs the p53 signaling in nasopharyngeal carcinoma."}, {"pubmed": 38241547, "text": "Prognostic value of cyclin B1 and cyclin B2 expression in breast cancer: A systematic review and updated meta-analysis."}, {"pubmed": 38300330, "text": "Upregulation of CCNB2 and a novel lncRNAs-related risk model predict prognosis in clear cell renal cell carcinoma."}], "genomic_pos": {"chr": "15", "end": 59125045, "ensemblgene": "ENSG00000157456", "start": 59105126, "strand": 1}, "genomic_pos_hg19": {"chr": "15", "end": 59417244, "start": 59397277, "strand": 1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0000079", "qualifier": "involved_in", "term": "regulation of cyclin-dependent protein serine/threonine kinase activity"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001701", "qualifier": "involved_in", "term": "in utero embryonic development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007057", "qualifier": "involved_in", "term": "spindle assembly involved in female meiosis I"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008315", "qualifier": "involved_in", "term": "G2/MI transition of meiotic cell cycle"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0040008", "qualifier": "involved_in", "term": "regulation of growth"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0043029", "qualifier": "involved_in", "term": "T cell homeostasis"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0044772", "qualifier": "involved_in", "term": "mitotic cell cycle phase transition"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048538", "qualifier": "involved_in", "term": "thymus development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051301", "qualifier": "involved_in", "term": "cell division"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0000307", "qualifier": "part_of", "term": "cyclin-dependent protein kinase holoenzyme complex"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005634", "qualifier": "is_active_in", "term": "nucleus"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005813", "qualifier": "is_active_in", "term": "centrosome"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005813", "pubmed": 21399614, "qualifier": "located_in", "term": "centrosome"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0015630", "qualifier": "located_in", "term": "microtubule cytoskeleton"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0016020", "qualifier": "located_in", "term": "membrane"}], "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [15232106, 17408621, 23455922, 24358021, 28514442], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0016538", "qualifier": "enables", "term": "cyclin-dependent protein serine/threonine kinase regulator activity"}, {"category": "MF", "evidence": "HDA", "id": "GO:0045296", "pubmed": 25468996, "qualifier": "enables", "term": "cadherin binding"}]}, "homologene": {"genes": [[3702, 838650], [3702, 843964], [4530, 4336670], [4530, 4342121], [4932, 856236], [7955, 368316], [8364, 100270772], [9031, 415400], [9598, 453478], [9606, 9133], [9615, 478324], [9913, 281668], [10090, 12442], [10116, 363088], [28985, 2893517], [33169, 4618511]], "id": 74359}, "interpro": [{"desc": "Cyclin, C-terminal domain", "id": "IPR004367", "short_desc": "Cyclin_C-dom"}, {"desc": "Cyclin, N-terminal", "id": "IPR006671", "short_desc": "Cyclin_N"}, {"desc": "Cyclin-like domain", "id": "IPR013763", "short_desc": "Cyclin-like_dom"}, {"desc": "Cyclin-like superfamily", "id": "IPR036915", "short_desc": "Cyclin-like_sf"}, {"desc": "Cyclin", "id": "IPR039361", "short_desc": "Cyclin"}, {"desc": "Cyclin A/B-like", "id": "IPR046965", "short_desc": "Cyclin_A/B-like"}, {"desc": "Cyclins, cyclin-box", "id": "IPR048258", "short_desc": "Cyclins_cyclin-box"}], "ipi": "IPI00028266", "map_location": "15q22.2", "name": "cyclin B2", "other_names": "G2/mitotic-specific cyclin-B2", "pantherdb": {"HGNC": "1580", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "88311", "ortholog_type": "LDO", "panther_family": "PTHR10177", "taxid": 10090, "uniprot_kb": "P30276"}, {"Ensembl": "ENSGALG00000004161", "ortholog_type": "LDO", "panther_family": "PTHR10177", "taxid": 9031, "uniprot_kb": "P29332"}, {"ZFIN": "ZDB-GENE-030429-12", "ortholog_type": "LDO", "panther_family": "PTHR10177", "taxid": 7955, "uniprot_kb": "F1QUY2"}, {"WormBase": "WBGene00000866", "ortholog_type": "O", "panther_family": "PTHR10177", "taxid": 6239, "uniprot_kb": "O45926"}, {"WormBase": "WBGene00000867", "ortholog_type": "O", "panther_family": "PTHR10177", "taxid": 6239, "uniprot_kb": "Q9BLB5"}, {"WormBase": "WBGene00000865", "ortholog_type": "LDO", "panther_family": "PTHR10177", "taxid": 6239, "uniprot_kb": "Q10653"}, {"FlyBase": "FBgn0000405", "ortholog_type": "LDO", "panther_family": "PTHR10177", "taxid": 7227, "uniprot_kb": "P20439"}, {"PomBase": "SPBC16E9.17c", "ortholog_type": "O", "panther_family": "PTHR10177", "taxid": 4896, "uniprot_kb": "O14332"}, {"dictyBase": "DDB_G0277439", "ortholog_type": "O", "panther_family": "PTHR10177", "taxid": 352472, "uniprot_kb": "Q8T2F2"}, {"dictyBase": "DDB_G0279085", "ortholog_type": "O", "panther_family": "PTHR10177", "taxid": 352472, "uniprot_kb": "Q1ZXI1"}, {"EnsemblGenome": "AT5G25380", "ortholog_type": "O", "panther_family": "PTHR10177", "taxid": 3702, "uniprot_kb": "Q39071"}, {"TAIR": "2148052", "ortholog_type": "O", "panther_family": "PTHR10177", "taxid": 3702, "uniprot_kb": "Q147G5"}, {"TAIR": "2196563", "ortholog_type": "O", "panther_family": "PTHR10177", "taxid": 3702, "uniprot_kb": "Q38819"}, {"TAIR": "2034250", "ortholog_type": "O", "panther_family": "PTHR10177", "taxid": 3702, "uniprot_kb": "Q9C968"}, {"TAIR": "2036761", "ortholog_type": "O", "panther_family": "PTHR10177", "taxid": 3702, "uniprot_kb": "A0MEB5"}, {"TAIR": "2030648", "ortholog_type": "O", "panther_family": "PTHR10177", "taxid": 3702, "uniprot_kb": "Q9C6A9"}, {"TAIR": "2036756", "ortholog_type": "O", "panther_family": "PTHR10177", "taxid": 3702, "uniprot_kb": "Q3ECW2"}, {"TAIR": "2167761", "ortholog_type": "O", "panther_family": "PTHR10177", "taxid": 3702, "uniprot_kb": "Q9FMH5"}, {"TAIR": "2031407", "ortholog_type": "O", "panther_family": "PTHR10177", "taxid": 3702, "uniprot_kb": "Q9FVX0"}, {"TAIR": "2205871", "ortholog_type": "O", "panther_family": "PTHR10177", "taxid": 3702, "uniprot_kb": "Q9C6Y3"}], "uniprot_kb": "O95067"}, "pathway": {"biocarta": {"id": "efppathway", "name": "estrogen responsive protein efp controls cell cycle and breast tumors growth"}, "kegg": [{"id": "hsa04068", "name": "FoxO signaling pathway - Homo sapiens (human)"}, {"id": "hsa04110", "name": "Cell cycle - Homo sapiens (human)"}, {"id": "hsa04114", "name": "Oocyte meiosis - Homo sapiens (human)"}, {"id": "hsa04115", "name": "p53 signaling pathway - Homo sapiens (human)"}, {"id": "hsa04218", "name": "Cellular senescence - Homo sapiens (human)"}, {"id": "hsa04914", "name": "Progesterone-mediated oocyte maturation - Homo sapiens (human)"}, {"id": "hsa05166", "name": "Human T-cell leukemia virus 1 infection - Homo sapiens (human)"}, {"id": "hsa05170", "name": "Human immunodeficiency virus 1 infection - Homo sapiens (human)"}], "netpath": {"id": "Pathway_TGF_beta_Receptor", "name": "TGF_beta_Receptor"}, "pid": [{"id": "deltanp63pathway", "name": "Validated transcriptional targets of deltaNp63 isoforms"}, {"id": "foxm1pathway", "name": "FOXM1 transcription factor network"}], "reactome": [{"id": "R-HSA-156711", "name": "Polo-like kinase mediated events"}, {"id": "R-HSA-162658", "name": "Golgi Cisternae Pericentriolar Stack Reorganization"}, {"id": "R-HSA-1640170", "name": "Cell Cycle"}, {"id": "R-HSA-1640170", "name": "Cell Cycle"}, {"id": "R-HSA-2500257", "name": "Resolution of Sister Chromatid Cohesion"}, {"id": "R-HSA-2514853", "name": "Condensation of Prometaphase Chromosomes"}, {"id": "R-HSA-2555396", "name": "Mitotic Metaphase and Anaphase"}, {"id": "R-HSA-2565942", "name": "Regulation of PLK1 Activity at G2/M Transition"}, {"id": "R-HSA-2980766", "name": "Nuclear Envelope Breakdown"}, {"id": "R-HSA-2980767", "name": "Activation of NIMA Kinases NEK9, NEK6, NEK7"}, {"id": "R-HSA-2995383", "name": "Initiation of Nuclear Envelope (NE) Reformation"}, {"id": "R-HSA-2995410", "name": "Nuclear Envelope (NE) Reassembly"}, {"id": "R-HSA-3301854", "name": "Nuclear Pore Complex (NPC) Disassembly"}, {"id": "R-HSA-453274", "name": "Mitotic G2-G2/M phases"}, {"id": "R-HSA-68875", "name": "Mitotic Prophase"}, {"id": "R-HSA-68875", "name": "Mitotic Prophase"}, {"id": "R-HSA-68877", "name": "Mitotic Prometaphase"}, {"id": "R-HSA-68877", "name": "Mitotic Prometaphase"}, {"id": "R-HSA-68882", "name": "Mitotic Anaphase"}, {"id": "R-HSA-68886", "name": "M Phase"}, {"id": "R-HSA-68886", "name": "M Phase"}, {"id": "R-HSA-69273", "name": "Cyclin A/B1/B2 associated events during G2/M transition"}, {"id": "R-HSA-69275", "name": "G2/M Transition"}, {"id": "R-HSA-69278", "name": "Cell Cycle, Mitotic"}, {"id": "R-HSA-69278", "name": "Cell Cycle, Mitotic"}, {"id": "R-HSA-69478", "name": "G2/M DNA replication checkpoint"}, {"id": "R-HSA-69481", "name": "G2/M Checkpoints"}, {"id": "R-HSA-69620", "name": "Cell Cycle Checkpoints"}, {"id": "R-HSA-8852276", "name": "The role of GTSE1 in G2/M progression after G2 checkpoint"}], "wikipathways": [{"id": "WP1530", "name": "miRNA regulation of DNA damage response"}, {"id": "WP179", "name": "Cell cycle"}, {"id": "WP2446", "name": "Retinoblastoma gene in cancer"}, {"id": "WP366", "name": "TGF-beta Signaling Pathway"}, {"id": "WP4754", "name": "IL-18 signaling pathway"}, {"id": "WP707", "name": "DNA damage response"}]}, "pfam": ["PF00134", "PF02984"], "pharmgkb": "PA26148", "pharos": {"target_id": 16606, "tdl": "Tbio"}, "pir": "T12530", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF259683", "relationship": "is"}, {"id": "GNF259684", "relationship": "is"}, {"id": "GNF259685", "relationship": "is"}, {"id": "GNF259686", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF038342", "relationship": "similar to"}, "GNF_mm+hs-MGC": [{"id": "GNF279315", "relationship": "is"}, {"id": "GNF279337", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF109202", "relationship": "is"}, {"id": "GNF116489", "relationship": "is"}, {"id": "GNF146181", "relationship": "is"}, {"id": "GNF156130", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000015.10", "NC_060939.1"], "protein": "NP_004692.1", "rna": "NM_004701.4", "translation": {"protein": "NP_004692.1", "rna": "NM_004701.4"}}, "reporter": {"GNF1H": "gnf1h06136_s_at", "HG-U133_Plus_2": ["202705_at", "232764_at", "232768_at"], "HG-U95Av2": "32263_at", "HTA-2_0": "TC15000449.hg.1", "HuEx-1_0": ["3595979", "3596002", "3626799", "3626801", "3626809"], "HuGene-1_1": "7983969", "HuGene-2_1": "16801557"}, "summary": "Cyclin B2 is a member of the cyclin family, specifically the B-type cyclins. The B-type cyclins, B1 and B2, associate with p34cdc2 and are essential components of the cell cycle regulatory machinery. B1 and B2 differ in their subcellular localization. Cyclin B1 co-localizes with microtubules, whereas cyclin B2 is primarily associated with the Golgi region. Cyclin B2 also binds to transforming growth factor beta RII and thus cyclin B2/cdc2 may play a key role in transforming growth factor beta-mediated cell cycle control. [provided by RefSeq, Jul 2008].", "symbol": "CCNB2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1332696"}, "unigene": "Hs.194698", "uniprot": {"Swiss-Prot": "O95067", "TrEMBL": ["H0YMP3", "H1UBN3"]}, "wikipedia": {"url_stub": "Cyclin B2"}}